Alexander H Gunn
Overview
Explore the profile of Alexander H Gunn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nouhravesh N, Gunn A, Cyr D, Hernandez A, Morrow D, Velazquez E, et al.
Eur J Heart Fail
. 2025 Jan;
PMID: 39792134
Aims: Whether prior treatment with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) modifies efficacy and safety of sacubitril/valsartan (Sac/Val) in patients with heart failure (HF) and ejection fraction...
2.
Gunn A, Fajardo J, DiBernardo L, Glass C, Alenezi F, Karra R, et al.
JACC CardioOncol
. 2024 Sep;
6(4):612-616.
PMID: 39239343
No abstract available.
3.
Gunn A, Murray E, Patel M, Mentz R
Am Heart J Plus
. 2024 Aug;
45:100435.
PMID: 39211004
Background: Climate change has been associated with adverse cardiovascular health, prompting interest in climate mitigation strategies while improving access for cardiovascular patients. We estimated greenhouse gas and air pollution savings...
4.
Contreras F, Pinsker B, Katz J, Russell S, Schroder J, Bryner B, et al.
JTCVS Open
. 2024 Jul;
19:175-182.
PMID: 39015460
Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD). Methods: Patients...
5.
6.
Gunn A, Warraich H, Mentz R
Am Heart J
. 2023 Dec;
269:94-107.
PMID: 38065330
With the implementation of new therapies, more patients are living with heart failure (HF) as a chronic condition. Alongside these advances, out-of-pocket (OOP) medical costs have increased, and patients experience...
7.
Frisco N, Gunn A, Wang F, Stang M, Kazaure H, Scheri R
J Surg Res
. 2022 Oct;
281:214-222.
PMID: 36191377
Introduction: Little is known about nationwide practice patterns for the management medullary thyroid cancer (MTC) in relation to the 2015 American Thyroid Association guidelines and their impact on survival. Methods:...
8.
Frisco N, Gunn A, Thomas S, Stang M, Scheri R, Kazaure H
Surgery
. 2022 Sep;
173(1):260-267.
PMID: 36150924
Background: Significant genotype-phenotype variability among multiple endocrine neoplasia type 2A patients with a RET V804M mutation has been reported. Methods: Patients with a RET V804M mutation treated at a single...
9.
Gunn A, Tashie C, Wolf S, Troy J, Zafar Y
Cancer Med
. 2022 Mar;
11(14):2865-2872.
PMID: 35289488
Background: Inflammatory responses from benign conditions can cause non-cancer-related elevations in tumor markers. The severe acute respiratory coronavirus 2 (SARS-CoV-2) induces a distinct viral inflammatory response, resulting in coronavirus disease...
10.
Gunn A, Frisco N, Thomas S, Stang M, Scheri R, Kazaure H
Thyroid
. 2021 Oct;
32(1):54-64.
PMID: 34663089
Graves' disease accounts for ∼80% of all cases of hyperthyroidism and is associated with significant morbidity and decreased quality of life. Understanding the association of total thyroidectomy with patient-reported quality-of-life...